Even though the markets trimmed the intra-day rally during closing hours on Wednesday, the benchmarks still moved modestly upward to achieve new highs. After-effects of...(
read more)
Shares of Icagen, Inc. (NASDAQ: ICGN) slumped as much as 26% after it announced that due to the occurrence of a serious adverse event in the photosensitivity study of ICA-105665, the Company...(
read more)
In a major setback, GenVec (GNVC) had to discontinue its final stage trial of TNFerade in patients with pancreatic cancer following an interim analysis. The interim...(
read more)